Middle East

US FDA approves Pfizer-BioNTech booster for children ages 12-15

Washington: The US Food and Drug Administration (FDA) has extended the Emergency Use Authorization for Pfizer-BioNTech Covid-19 Vaccine Booster to children ages 12-15.

On Monday, the FDA reduced the booster shot duration from at least 6 months to at least 5 months after the completion of the first series, according to the Xinhua News Agency.

Authorities have stated that the health benefits of a single booster of the Pfizer-BioNTech Covid-19 vaccine to provide continued protection against the virus and the associated serious consequences are potential for individuals aged 12 to 15 years. I decided that it would exceed the risk.

MS Education Academy

Authorities said there were “no new safety concerns” after shooting boosters at young teens, with new reports of two types of heart inflammation associated with boosters called myocarditis or pericarditis. Said he didn’t.

This decision was made because the Omicron variant spread rapidly throughout the United States, resulting in record high hospitalizations among young people.

subscribe SiasatDaily-Google News

https://www.siasat.com/us-fda-authorizes-pfizer-biontech-boosters-for-kids-aged-12-15-2253487/ US FDA approves Pfizer-BioNTech booster for children ages 12-15

Back to top button